Global Companion Animal Healthcare Market

Companion Animal Healthcare Market Size, Share, Growth Analysis, By Type(Pharmaceuticals, Vaccines), By Application(Veterinary Hospitals, Veterinary Clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35E2026 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Companion Animal Healthcare Market size was valued at USD 21.5 billion in 2021 and is poised to grow from USD 23.31 billion 2022 to USD 44.43 billion by 2030, growing at a CAGR of 8.4% during the forecast period (2023-2030).

The companion animal healthcare market is highly competitive and comprises a wide range of players, including pharmaceutical companies, veterinary clinics, diagnostic laboratories, and pet healthcare product manufacturers. The market is driven by the increasing pet ownership rates, growing awareness about animal health, and the rising demand for advanced veterinary care. 'Zoetis Inc. (US)', 'Merck & Co., Inc. (US)', 'Elanco Animal Health Incorporated (US)', 'Boehringer Ingelheim GmbH (Germany)', 'Bayer AG (Germany)', 'Virbac (France)', 'Ceva Santé Animale (France)', 'Vetoquinol S.A. (France)', 'IDEXX Laboratories, Inc. (US)', 'Dechra Pharmaceuticals PLC (UK)', 'Norbrook Holdings Limited (UK)', 'Kindred Biosciences, Inc. (US)', 'Heska Corporation (US)', 'Phibro Animal Health Corporation (US)', 'Nutramax Laboratories Veterinary Sciences, Inc. (US)', 'Merial (Sanofi S.A.) (France)', 'Neogen Corporation (US)', 'PetIQ, Inc. (US)', 'AniCura AB (Sweden)', 'VCA Inc. (US)'

The deep emotional connection between humans and their companion animals is a key driver for the demand in high-quality healthcare services. Pet owners prioritize the well-being of their animals and are willing to invest in specialized care, medications, and supplements to ensure their pets' longevity and enhance their overall quality of life. This emotional bond fuels the growth of the companion animal healthcare market as pet owners seek comprehensive healthcare solutions.

A key market trend in the companion animal healthcare market is the growing focus on preventive healthcare for pets. Pet owners are increasingly recognizing the importance of maintaining their companion animals' overall health and well-being, rather than solely addressing illness or disease. This shift in mindset has led to a rise in the demand for preventive healthcare products and services, including vaccinations, regular check-ups, parasite control, and nutritional supplements for pets.

In the companion animal healthcare market, the most dominant region is North America. North America has a well-established and mature market for companion animal healthcare, driven by factors such as high pet ownership rates, advanced veterinary healthcare infrastructure, and increased spending on pet healthcare products and services. The region is home to a large number of key market players and veterinary hospitals, contributing to its dominant position in the market.

Related Reports

Medical Tourism Market
Buy Now GET FREE SAMPLE
Spinal Imaging Market
Buy Now GET FREE SAMPLE
Acute Hospital Care Market
Buy Now GET FREE SAMPLE
Pet Boarding Services Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Companion Animal Healthcare Market

Product ID: SQMIG35E2026

$5,300
BUY NOW